Siam Bioscience breaks silence on Thai vaccine deal after Thanathorn criticism


BANGKOK (The Nation/ANN): Siam Bioscience on Monday (Jan 25) released a statement following criticism by Progressive Movement leader Thanathorn Juangroongruangkit over its role in Thailand’s Covid-19 vaccine programme.

Last Monday Thanathorn slammed the government for slowness in providing vaccines, and questioned the transparency of giving a company owned by the Crown Property Bureau – Siam Bioscience – the right to manufacture the AstraZeneca vaccine locally.

Limited time offer:
Just RM5 per month.

Monthly Plan

RM13.90/month
RM5/month

Billed as RM5/month for the 1st 6 months then RM13.90 thereafters.

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Thailand , Siam Bioscience , Thanathorn , vaccine

   

Next In Aseanplus News

China’s cheap EVs redraw the map of where cars get made
China wants everyone to trade in their old cars, fridges to help save its economy
Seoul studies RM350,000 cash incentive for each child born
New Chinese EV manufacturer Chery to invest in Thailand
Major water disruptions in Brunei-Muara Districts due to repair works
‘My goodbye to her was my last’: Friends say teen killed in Tampines accident was bright, friendly
Surging land value sends price of new Bangkok condos soaring
HK$888,888 for a set of plastic utensils? Hongkongers have some fun with ban
Myanmar’s figurehead vice president, a rare holdover from Suu Kyi's civilian government, steps down
Oil will keep drawing strength from Middle East geopolitics, OPEC+ strategy for now

Others Also Read